Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Vaccinex, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 25 | 2 | 24 | +1 |
| Shares | 4.69M | 416.2K | 2.76M | −1.51M (−35.3%) |
| Value | $3.12M | $268.1K | $1.10M | −$1.74M (−61.3%) |
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Vaccinex, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 103,898 | $42.0K | 0.00% |
| Susquehanna International Group, LLP | 99,105 | $39.6K | 0.00% |
| Two Sigma Securities, LLC | 32,305 | $12.9K | 0.00% |
| Tower Research Capital LLC (TRC) | 24,274 | $10.0K | 0.00% |
| Financial Connections Group, Inc. | 4,044 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Vaccinex, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Vectors Research Management, LLC | 10,000 | $6.00K |
| Money Concepts Capital Corp | 110 | $71 |
| Bank of America Corp | 54 | $34 |
| CWM, LLC | 300 | $0 |
Not filed for Q1 2023 yet (2)
Institutions that held Vaccinex, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Telemetry Investments, L.L.C. | 416,000 | $268.0K |
| Cornerstone Planning Group LLC | 200 | $122 |